Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$68,257,350
+$9,412,821 QoQ
Shares Held
271,250
+0.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
17.71%
of 13F equity value
Holder Rank
#313
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $82,370,025 across 15 Drug Manufacturers - General names. ABBV ranks #1 (82.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
271,250 | $68,257,350 | |
| 2 | JNJ |
Johnson & Johnson
|
14,678 | $3,727,771 | |
| 3 | AMGN |
Amgen Inc
|
8,630 | $3,125,095 | |
| 4 | LLY |
ELI LILLY & Co
|
2,477 | $2,970,988 | |
| 5 | MRK |
Merck & Co., Inc.
|
22,792 | $2,928,772 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,582 | $957,909 | |
| 7 | PFE |
Pfizer Inc
|
10,065 | $242,365 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,153 | $66,435 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,257,350 | 271,250 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $58,844,529 | 270,562 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $61,861,611 | 270,741 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $62,635,043 | 270,515 | Shares | Sole | 2026-02-23 | |
| 2025-06-30 | $50,230,442 | 270,609 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $56,784,738 | 271,023 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $47,389,746 | 266,684 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $52,648,760 | 266,603 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $45,557,427 | 265,610 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $48,352,284 | 265,526 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $41,065,500 | 264,990 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $39,487,484 | 264,910 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $35,630,695 | 264,460 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $42,505,094 | 266,707 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $36,693,065 | 227,047 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $30,448,759 | 226,874 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $35,330,642 | 230,678 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $31,185,262 | 192,371 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $26,034,712 | 192,280 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,624,306 | 15,058 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,602,078 | 14,223 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,465,407 | 13,541 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,273,370 | 11,884 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $921,096 | 10,516 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $461,053 | 4,696 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $27,428 | 360 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||